IQVIA CEO to Address Leerink 2026 Conference
RESEARCH TRIANGLE PARK, N.C., March 2, 2026 IQVIA Holdings Inc. (NYSE: IQV) announced that Chairman and Chief Executive Officer...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
RESEARCH TRIANGLE PARK, N.C., March 2, 2026 IQVIA Holdings Inc. (NYSE: IQV) announced that Chairman and Chief Executive Officer...
SAN FRANCISCO, January 12, 2026 — NVIDIA and Eli Lilly and Company announced the creation of a first-of-its-kind AI...
New York, NY — December 2, 2025 — A newly released industry analysis reveals that the Life Science Automation...
Tel Aviv — November 19, 2025 — Teva Pharmaceutical Industries Ltd. has launched Teva Rise, a groundbreaking global open-innovation...
